Senate Bill Provides Remedy for Regulatory Abuse Keeping Generics Off the Market

I’d like to begin by discussing Geoff’s post on the pending legislative proposals designed to combat strategic abuse of drug safety regulations to prevent generic competition. Specifically, I’d like to address the economic incentive structure that is in effect in this highly regulated market.

Read the full piece here.